EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hand-foot syndrome in cancer patients on capecitabine: examining prevalence, impacts, and associated risk factors at a cancer centre in Malaysia

Teck Long King iD, Pei Jye Voon iD, Kah Hay Yuen iD, Dzul Azri Mohamed Noor iD

Supportive Care in Cancer · 2024

DOI: 10.1007/s00520-024-08490-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von Teck Long King und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Centre, Sarawak General Hospital, Ministry of Health, Kuching, Sarawak, Malaysia. Hauptthemen laut MEDLINE: Capecitabine, Hand-Foot Syndrome, Neoplasms, Antimetabolites, Antineoplastic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hand-foot syndrome (HFS) significantly impacts quality of life in cancer patients undergoing capecitabine treatment. This study assessed capecitabine-associated HFS prevalence, its impacts on chemotherapy treatment, and identified risk factors in multiracial Malaysian patients.

Methods

We included adult cancer patients receiving capecitabine at Sarawak General Hospital for at least two cycles from April 1, 2021 to June 30, 2022. HFS rates, time to HFS, and proportions of HFS-related treatment modifications were determined. Characteristics between patients with and without HFS were compared and multivariable logistic regression was used to identify risk factors for all-grade HFS and grade ≥2.

Results

Among 369 patients, 185 (50.1%) developed HFS, with 14.6% experiencing grade ≥2 and 21.6% (40/185) underwent treatment modifications. Risk factors for all-grade HFS include older age (OR 1.03 95%CI 1.01, 1.06), prior chemotherapy (OR 2.09 95%CI 1.22, 3.58), higher capecitabine dose (OR 2.96 95%CI 1.62, 5.38), prolonged treatment (OR 1.36 95%CI 1.21, 1.51), folic acid intake (OR 3.27 95%CI 1.45, 7.35) and lower neutrophil count (OR 0.77 95%CI 0.66, 0.89). For HFS grade ≥2, older age (OR 1.04 95%CI 1.01, 1.08), female sex (OR 2.10 95%CI 1.05, 4.18), Chinese race (OR 2.10 95%CI 1.06, 4.18), and higher capecitabine dose (OR 2.62 95%CI 1.28, 5.35) are significant risk factors. Use of calcium channel blockers were associated with reduced risks of all-grade HFS (OR 0.27, 95%CI 0.12, 0.60) and grade ≥2 (OR 0.21 95%CI 0.06, 0.78).

Conclusion

This study provides real-world data on capecitabine-induced HFS in Malaysian patients and identifies risk factors that may offer insights into its understanding and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CapecitabineHand-Foot SyndromeNeoplasmsAntimetabolites, AntineoplasticHumansMalaysiaMaleFemaleMiddle AgedRisk FactorsPrevalenceAgedAdultQuality of Life

Stichwörter der Autor:innen

Hand-foot syndromecapecitabinechemotherapyfluoropyrimidinespalmar-plantar erythrodysesthesia

Substanzen

CapecitabineAntimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Clinical Research Centre, Sarawak General Hospital, Ministry of Health, Kuching, Sarawak, Malaysia.
  • School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
  • Department of Radiotherapy, Oncology and Palliative Care, Sarawak General Hospital, Ministry of Health, Kuching, Sarawak, Malaysia.
  • School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia. dzulazri@usm.my.

ORCID-Profile: Teck Long King, Pei Jye Voon, Kah Hay Yuen, Dzul Azri Mohamed Noor

Zitieren

APA

King, T. L., Voon, P. J., Yuen, K. H., & Mohamed Noor, D. A. (2024). Hand-foot syndrome in cancer patients on capecitabine: examining prevalence, impacts, and associated risk factors at a cancer centre in Malaysia. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-08490-7

Vancouver

King TL, Voon PJ, Yuen KH, Mohamed Noor DA. Hand-foot syndrome in cancer patients on capecitabine: examining prevalence, impacts, and associated risk factors at a cancer centre in Malaysia. Supportive Care in Cancer. 2024. doi:10.1007/s00520-024-08490-7

BibTeX
@article{King2024,
  author = {King, Teck Long and Voon, Pei Jye and Yuen, Kah Hay and Mohamed Noor, Dzul Azri},
  title = {Hand-foot syndrome in cancer patients on capecitabine: examining prevalence, impacts, and associated risk factors at a cancer centre in Malaysia},
  journal = {Supportive Care in Cancer},
  year = {2024},
  doi = {10.1007/s00520-024-08490-7}
}
Kostenlos starten →